Peginterferon alfa‐2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy

BACKGROUND: The management of patients with chronic hepatitis C who have relapsed or failed to respond to interferon based therapies is an important issue facing hepatologists. AIMS: We evaluated the efficacy and safety of peginterferon alfa‐2a (40KD) plus ribavirin in this population by conducting...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Sherman, M, Yoshida, E M, Deschenes, M, Krajden, M, Bain, V G, Peltekian, K, Anderson, F, Kaita, K, Simonyi, S, Balshaw, R, Lee, S S
格式: Artigo
語言:Inglês
出版: BMJ Group 2006
主題:
Hepatitis
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC1860092/
https://ncbi.nlm.nih.gov/pubmed/16709661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.083113
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍